In this article (2016):
https://asia.nikkei.com/Business/Kyocera-to-join-hair-regeneration-research-project
Is mentioned:
„
The trio aims to begin human clinical studies by 2020.“
and:
„If the research proceeds as planned, Kyoto-based Kyocera hopes to
launch a business in 2020 acting as a contract manufacturer for medical institutions. Kyocera's planned business model is to receive scalp tissue from the clinic, process it over the course of around three weeks, and then return the propagated hair follicles back to the clinic.“
So back in 2016 there was a Plan to conduct human clinical trials in 2020 and commercialization so i assume a little chance to see Tsuji on the market this year.
The safety trial must be over so I am very disappointed of Organ technologies not giving us an update, whether the treatment is safe and what is the timeline...
I emailed Organ Technologies, RIKEN and Kyocera multiple times without getting serious answers.
Very disappointing. I know we will not see the product earlier on the market if we all contact them but maybe if we all write Organ Technologies, they will give us an official update and will bring some light in the darkness.
I would be happy if everybody who wants to know more about Tsujis timeline to write an
E-Mail to:
info@organ-technol.co.jp
I am sure that our community is strong enough to force an serious official update of Organ Technologies about Safety trials and human trial plans.
Thank you all!